SAFETY AND IMMUNOGENICITY OF A LIVE RECOMBINANT MEASLES VECTOR BASED CHIKUNGUNYA VACCINE IN HEALTHY ADULTS: A RANDOMIZED, PLACEBO CONTROLLED PHASE 2 STUDY

被引：0
|
作者：
Schrauf, Sabrina [1 ]
Ramsauer, Katrin [1 ]
Muellner, Matthias [1 ]
Pfeiffer, Andrea [1 ]
Kort, Alexander [1 ]
Tauber, Erich [1 ]
机构：
[1] Themis Biosci GmbH, Vienna, Austria
来源：
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2017年 / 97卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
2
引用
下载
收藏
页码：1 / 1
页数：1
相关论文
共 50 条
  • [21] A Phase 1 Randomized Placebo-Controlled Study to Assess the Safety, Immunogenicity and Genetic Stability of a New Potential Pandemic H7N9 Live Attenuated Influenza Vaccine in Healthy Adults
    Kiseleva, Irina
    Isakova-Sivak, Irina
    Stukova, Marina
    Erofeeva, Marianna
    Donina, Svetlana
    Larionova, Natalie
    Krutikova, Elena
    Bazhenova, Ekaterina
    Stepanova, Ekaterina
    Vasilyev, Kirill
    Matyushenko, Victoria
    Krylova, Marina
    Galatonova, Julia
    Ershov, Aleksey
    Lioznov, Dmitry
    Sparrow, Erin Grace
    Torelli, Guido
    Rudenko, Larisa
    VACCINES, 2020, 8 (02) : 1 - 20
  • [22] Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218
    Edelman, R
    Tacket, CO
    Wasserman, SS
    Bodison, SA
    Perry, JG
    Mangiafico, JA
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2000, 62 (06): : 681 - 685
  • [23] Safety and immunogenicity of a tetravalent dengue vaccine in healthy children aged 2-11 years in Malaysia: A randomized, placebo-controlled, Phase III study
    Hss, Amar-Singh
    Koh, Mia-Tuang
    Tan, Kah Kee
    Chan, Lee Gaik
    Zhou, Lynn
    Bouckenooghe, Alain
    Crevat, Denis
    Hutagalung, Yanee
    VACCINE, 2013, 31 (49) : 5814 - 5821
  • [24] Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial
    Zhu, Feng-Cai
    Wurie, Alie H.
    Hou, Li-Hua
    Liang, Qi
    Li, Yu-Hua
    Russell, James B. W.
    Wu, Shi-Po
    Li, Jing-Xin
    Hu, Yue-Mei
    Guo, Qiang
    Xu, Wen-Bo
    Wurie, Abdul R.
    Wang, Wen-Juan
    Zhang, Zhe
    Yin, Wen-Jiao
    Ghazzawi, Manal
    Zhang, Xu
    Duan, Lei
    Wang, Jun-Zhi
    Chen, Wei
    LANCET, 2017, 389 (10069): : 621 - 628
  • [25] Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1-2 dose-ranging study ,
    Goepfert, Paul A.
    Fu, Bo
    Chabanon, Aeine-Laure
    Bonaparte, Matthew, I
    Davis, Matthew G.
    Essink, Brandon J.
    Frank, Ian
    Haney, Owen
    Janosczyk, Helene
    Keefer, Michael C.
    Koutsoukos, Marguerite
    Kimmel, Murray A.
    Masotti, Roger
    Savarino, Stephen J.
    Schuerman, Lode
    Schwartz, Howard
    Sher, Lawrence D.
    Smith, Jon
    Tavares-Da-Silva, Fernanda
    Gurunathan, Sanjay
    DiazGranados, Carlos A.
    de Bruyn, Guy
    LANCET INFECTIOUS DISEASES, 2021, 21 (09): : 1257 - 1270
  • [26] Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial
    Ramsauer, Katrin
    Schwameis, Michael
    Firbas, Christa
    Muellner, Matthias
    Putnak, Robert J.
    Thomas, Stephen J.
    Despres, Philippe
    Tauber, Erich
    Jilma, Bernd
    Tangy, Frederic
    LANCET INFECTIOUS DISEASES, 2015, 15 (05): : 519 - 527
  • [27] Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons
    Lisa A Jackson
    Manjusha J Gaglani
    Harry L Keyserling
    John Balser
    Nancy Bouveret
    Louis Fries
    John J Treanor
    BMC Infectious Diseases, 10
  • [28] Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons
    Jackson, Lisa A.
    Gaglani, Manjusha J.
    Keyserling, Harry L.
    Balser, John
    Bouveret, Nancy
    Fries, Louis
    Treanor, John J.
    BMC INFECTIOUS DISEASES, 2010, 10
  • [29] Recombinant gp350 vaccine for infectious mononucleosis: A phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults
    Sokal, Etienne M.
    Hoppenbrouwers, Karel
    Vandermeulen, Corinne
    Moutschen, Michel
    Leonard, Philippe
    Moreels, Andre
    Haumont, Michele
    Bollen, Alex
    Smets, Francoise
    Denis, Martine
    JOURNAL OF INFECTIOUS DISEASES, 2007, 196 (12): : 1749 - 1753
  • [30] Immunogenicity and safety of a severe acute respiratory syndrome coronavirus 2 inactivated vaccine in healthy adults: randomized, double-blind, and placebo-controlled phase 1 and phase 2 clinical trials
    Pan, Hong-Xing
    Liu, Jian-Kai
    Huang, Bao-Ying
    Li, Gui-Fan
    Chang, Xian-Yun
    Liu, Ya-Fei
    Wang, Wen-Ling
    Chu, Kai
    Hu, Jia-Lei
    Li, Jing-Xin
    Zhu, Dan-Dan
    Wu, Jing-Liang
    Xu, Xiao-Yu
    Zhang, Li
    Wang, Meng
    Tan, Wen-Jie
    Huang, Wei-Jin
    Zhu, Feng-Cai
    CHINESE MEDICAL JOURNAL, 2021, 134 (11) : 1289 - 1298
12345